Oman Society of Rheumatology Conference 2026
Scientific Agenda
Day 1: Thursday, 23 April
Parallel Workshops
Parallel Workshops
Day 2: Friday, 24 April
Adult Rheumatology
Parallel Session
Adult Rheumatology
Parallel Session
Day 2: Friday, 24 April
Pediatric Rheumatology
Parallel Session
Pediatric Rheumatology
Parallel Session
Day 3: Saturday, 25 April
Adult & Pediatric Rheumatology
Adult & Pediatric Rheumatology
Day 1: Thursday, 23 April
Parallel Workshops
Parallel Workshops
| 14:00 | Registration | |||
| 16:00 – 18:30 | Workshop 1 | Workshop 2 | Workshop 3 | Workshop 4 |
| Rheumatology Emergency & Crystal Arthropathy | Artificial Intelligence in Rheumatology | Rheumatology for Nurses | Interpretation of Pediatric MSK images | |
| Dr. Ahmed Al Muqbali, Oman Dr. Humaid Al Wahshi, OmanDr. Razan Al Yaarubi, Oman | Dr. Adhari Al Zaabi, Oman | Dr. Khoula Al Maqbali, Oman | Dr. Mohammed Al Salman, KSA | |
| 18:30 – 19:00 | Coffee Break | |||
| 19:00 – 19:30 | Opening Ceremony | |||
| 19:30 – 20:30 | Keynote Lecture: Genetics, Immunity, Autoimmunity, & Rheumatic Disease – Where are We? | Prof. Fayhan Alroqi, KSA | ||
| 20:30 – 21:30 | Industry Symposium | |||
| 21:30 | Gala Dinner and Networking Reception | |||
| END OF DAY 1 | ||||
Day 2: Friday, 24 April
Adult Rheumatology
Parallel Session
Adult Rheumatology
Parallel Session
Â
| 08:00 – 17:00 | Registration | ||
| 08:25 – 08:30 | Opening Remarks | ||
| Â | Session 1: Inflammatory Arthritis & Beyond Moderators: TBA | ||
| 08:30 – 09:10 | Oral vs Injectable Therapies: Which Will Prevail in Rheumatoid Arthritis Management? | Dr. Rajaie Namas, UAE | |
| 09:10 – 09:40 | Psoriatic Arthritis (PsA) from Diagnosis to Management | Dr. Ghaydaa Aldabie, Kuwait | |
| 09:40 – 09:50 | Q&A | ||
| 09:50 – 10:20 | Industry Symposium | ||
| 10:20 – 10:35 | Coffee & Refreshment Break | ||
| Â | Session 2: The Specialities Interface 1 Moderators: TBA | ||
| 10:35 – 11:00 | The GI – Rheumatology Interface: When to Worry about Inflammatory Bowel Disease (IBD) in Spondylarthritis (SpA) Patients | Dr. Ikram Nasr, Oman | |
| 11:00 – 11:30 | The Ophthalmology – Rheumatology Interface (The Eye Looking Inside) | Dr. Majid Al Shaaibi, Oman | |
| 11:30 – 12:00 | The Neuro – Rheumatology Interface: When the Immune System Targets the Nervous System | Dr. Ahmed Al Saadi, Oman | |
| 12:00 – 12:10 | Q&A | ||
| 12:00 – 14:00 | Prayer & Lunch | ||
| Â | Session 3: The Specialities Interface 2 Moderators: TBA | ||
| 14:00 – 14:30 | Immune Dysregulation: Insights into the Pathogenesis of Connective Tissue Diseases | Dr. Shuayb El – Khalifa, UAE | |
| 14:30 – 15:00 | The Neuro-Rheumatology Interface: When the Immune System Targets the Nervous System | Dr. Ahmed Al Saadi, Oman | |
| 15:00 – 15:30 | Malignancy & Rheumatic Diseases | Dr. Abdallah Al Alawi, Oman | |
| 15:30 – 15:40 | Q&A | ||
| 15:40 – 16:10 | Industry Symposium | ||
| 16:10 – 16:30 | Poster Viewing & Coffee Break | ||
| Â | Session 4: Vasculitis & CTDs Moderators: TBA | ||
| 16:30 – 17:00 | Takayasu Vasculitis: From Diagnosis to Management | Prof. Ömer Karadağ, Turkey | |
| 17:00 – 17:30 | Sjögren’s Syndrome: A Disease with Multiple Faces and Limited Effective Treatment | Dr. Razan Al Yaarubi, Oman | |
| 17:30 – 18:00 | Updates in the Management of Behçet’s Disease | Prof. Ömer Karadağ, Turkey | |
| 18:00 – 18:10 | Q&A | ||
| END OF DAY 2 | |||
Day 2: Friday, 24 April
Pediatric Rheumatology
Parallel Session
Pediatric Rheumatology
Parallel Session
| 07:30 | Registration | |
| 08:50 – 08:55 | Opening Remarks | |
| Â | Session 1: Autoinflammatory Diseases Moderators: TBA | |
| 09:00 – 09:45 | Interferonopathies and Janus Kinase Inhibitors (JAK): Precision Medicine in Action | Dr. Buthaina Al Adhaba, Qatar |
| 09:45 – 10:15 | Acquired Immunodeficiency Syndrome (AIDS) Experience in Oman Beyond Antineutrophil Cytoplasmic Antibodies (ANCA): Monogenic Vasculitis in Children | Dr. Ruqaiya Al Jashmi, Oman |
| 10:15 – 10:25 | Q&A | |
| 10:25 – 10:40 | Coffee Break | |
| Â | Session 2: Vasculitis Moderators: TBA | |
| 10:40 – 11:10 | Beyond ANCA: Monogenic Vasculitis in Children | Dr. Hanof Al Khader, Kuwait |
| 11:10 – 11:40 | Vasculitis or Not? Lessons from Challenging Pediatric Cases | Dr. Dalila Al Julandani,Oman |
| 11:40 – 12:10 | When the Kidney Speaks First: Vasculitis Presenting with Renal Disease | Dr. Mohammed Al Riyami, Oman |
| 12:10 – 12:20 | Q&A | |
| 12:20 – 14:00 | Prayer & Lunch | |
| Â | Session 3: Hyperinflammatory Syndromes Moderators: TBA | |
| 14:00 – 14:30 | MAS vs Sepsis vs MIS – C: How to Tell Them Apart | Dr. Eman Al Masroori, Oman |
| 14:30 – 15:00 | When Hyperinflammation Is an Inborn Error of Immunity | Dr. Amer Khojah, KSA |
| 15:00 – 15:30 | At the Crossroads of Inflammation: A Unified Approach to Hemophagocytic Lymphohistiocytosis (HLH) | Dr. Alyaa Al Mughairy, Oman |
| 15:30 – 15:40 | Q&A | |
| 15:40 – 15:50 | Coffee Break | |
| Â | Session 4: Genetics/Metabolic Moderators: TBA | |
| 15:50 – 16:20 | Genotype–Phenotype Correlation in Rare Monogenic Autoinflammatory Syndromes | Dr. Khalid Al Dhuhli, Oman |
| 16:20 – 16:50 | Diagnostic Yield of Next-Generation Sequencing in Unexplained Paediatric Hyperinflammation | Dr. Fathiya Al Murshidi, Oman |
| 16:50 – 17:20 | When Myositis Is Not Inflammatory | Dr. Aisha Al Balushi, Oman |
| 17:20 – 17:30 | Q&A | |
| End of Pediatric Track | ||
Day 3: Saturday, 25 April
Adult & Pediatric Rheumatology
Adult & Pediatric Rheumatology
| 08:00 | Registration | |
| Â | Session 5: Pediatric Diseases and Beyond Moderators: TBA | |
| 09:00 – 09:40 | Juvenile Idiopathic Arthritis (JIA): A Focus on Management | Prof. A.V Ramanan, UK |
| 09:40 – 10:20 | Where Are We Heading in Lupus Management? | Prof. Laurent Arnaud, France |
| 10:20 – 10:30 | Q&A | |
| 10:30 – 11:00 | Industry Symposium | |
| 11:00 – 11:15 | Coffee Break | |
| Â | Session 6: Connective Tissue Diseases (CTDs) in the ICU and the Clinic Moderators: TBA | |
| 11:15 – 11:55 | Macrophage Activation Syndrome (MAS) and Churg–Strauss Syndrome (CSS): One Disease Spectrum or Distinct Conditions? | Prof. A.V Ramanan, UK |
| 11:55 – 12:30 | Treating the Unusual in Systemic Lupus Erythematosus (SLE): Should We Use the Unusual Drugs? | Prof. Laurent Arnaud, France |
| 12:30 – 13:00 | Approach to Genetic Investigations in Rheumatology with Suspected Inborn Errors of Immunity (IEI) | Prof. Fayhan Alroqi, KSA |
| 13:00 – 13:10 | Q&A | |
| 13:10 – 13:30 | Closing Remarks (Followed by Lunch) | |
| END OF DAY 3 | ||
Disclaimer: Agenda as of 23 February 2026, subject to potential modifications without prior notification.